Bank Of Montreal Bria Cell Therapeutics Corp. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$5.72 - $7.58 $138,017 - $182,897	24,129 Added 229.8%	34,629 $222,000
Q1 2023 Jun 13, 2024	BUY	$4.59 - $7.99 $115,420 - $200,916	25,146 New	25,146 $187,000
Q3 2022 Nov 10, 2022	BUY	$3.0 - $8.31 $31,500 - $87,255	10,500 New	10,500 $61,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $9.16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.